
AVITA Medical RCEL
$ 4.84
-2.42%
Annual report 2025
added 02-12-2026
AVITA Medical Total Liabilities 2011-2026 | RCEL
Annual Total Liabilities AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 73 M | 75 M | 61.9 M | 13 M | 11.4 M | 10.1 M | 4.87 M | 2.95 M | 1.96 M | 1.31 M | 941 K | 1.68 M | 2.24 M | 2.2 M | 1.54 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 75 M | 941 K | 17.6 M |
Quarterly Total Liabilities AVITA Medical
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70.4 M | 74.1 M | 75 M | 68.6 M | 63.5 M | 64 M | 61.9 M | 17.4 M | 16.5 M | 14.3 M | 13 M | 11.7 M | 9.95 M | 8.68 M | 11.4 M | 9.68 M | 9.85 M | 9.85 M | 9.71 M | 9.93 M | 10.1 M | 10.1 M | - | - | 4.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 75 M | 4.95 M | 28.4 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
126 M | $ 12.53 | -3.62 % | $ 1.88 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Aziyo Biologics
AZYO
|
82 M | - | 1.37 % | $ 20.5 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
3.99 B | $ 38.91 | 1.06 % | $ 5.8 K | ||
|
Cognyte Software Ltd.
CGNT
|
281 M | $ 8.34 | 1.81 % | $ 599 M | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
AdaptHealth Corp.
AHCO
|
2.79 B | $ 9.43 | -2.48 % | $ 1.27 B | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Electromed
ELMD
|
10.6 M | $ 24.19 | -0.41 % | $ 205 M | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 41.83 | -2.71 % | $ 1.3 B | ||
|
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.17 | -2.0 % | $ 155 M | ||
|
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
92.8 M | $ 28.81 | -1.4 % | $ 1.33 B | ||
|
Apyx Medical Corporation
APYX
|
52.3 M | $ 3.25 | -1.66 % | $ 113 M | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | ||
|
FONAR Corporation
FONR
|
53.1 M | $ 18.48 | -0.3 % | $ 121 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
389 M | $ 0.52 | -0.63 % | $ 53.4 M | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.81 | 2.41 % | $ 44.1 M | ||
|
Align Technology
ALGN
|
2.36 B | $ 175.06 | -3.9 % | $ 13.1 B | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Butterfly Network
BFLY
|
87.2 M | $ 3.7 | -8.2 % | $ 783 M | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
36.6 B | $ 111.16 | -1.67 % | $ 194 B | ||
|
InMode Ltd.
INMD
|
83.2 M | $ 13.46 | -0.74 % | $ 870 M | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
16.7 B | $ 71.3 | -1.26 % | $ 106 B | ||
|
IRadimed Corporation
IRMD
|
11.5 M | $ 101.75 | -3.2 % | $ 1.29 B | ||
|
IRIDEX Corporation
IRIX
|
24.9 M | $ 1.42 | 0.71 % | $ 22.9 M | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 17.62 | -4.65 % | $ 413 M | ||
|
Pulmonx Corporation
LUNG
|
77 M | $ 1.61 | 11.81 % | $ 63 M | ||
|
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.29 | -0.87 % | $ 1.39 M | ||
|
Medtronic PLC
MDT
|
43.4 B | $ 92.96 | -2.76 % | $ 120 B | ||
|
Medigus Ltd.
MDGS
|
20 M | - | 10.28 % | $ 55.5 M | ||
|
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 83.96 | -1.48 % | $ 49.1 B |